Open with CtrlK — press Esc to close
The FDA approved Fayuvi (rebisufligene etisparvovec-hopf) on Sept. 17, 2026, making it the first treatment designed to alter the course of mucopolysaccharidosis type IIIA (MPS IIIA), a rare inherited…
Give GPT-2 the unfinished sentence "Why are women so" and sexual violence is among the things it finishes with. Give the same fragment to GPT-5, and you get measured, even-handed prose that every…
A team at MIT, Harvard Medical School, and several U.S. hospitals has published a method that lines up a live X-ray taken during a procedure with the three-dimensional scan a patient had beforehand,…
Researchers at the MRC Laboratory of Molecular Biology in Cambridge and the University of Bern report that cells keep watch over glycogen, the body's short-term store of sugar, and destroy the faulty…
The US Food and Drug Administration has approved Bexlutry, an injected radiation therapy made by Curium, for adults with a rare group of tumors that begin in the digestive tract and pancreas. Curium…
Prediction models that use a patient's medical history to estimate whether their tuberculosis will resist fluoroquinolones should not be assumed to work in a country they were not built for until…
Blood samples from people with relapsing multiple sclerosis carry a repeatable pattern of immune activity up to three months before an attack, and the genes behind it are ones the Epstein-Barr virus…
The World Health Organization has validated Chile as having eliminated dog-transmitted rabies as a public health problem, the first country in South America to receive it. The Pan American Health…
Researchers in Denmark, Britain and the United States have re-read the randomized trials of mammography screening within a single framework and report that the trials are compatible with…
Researchers who analyzed the genetics of Alzheimer's disease separately in carriers and non-carriers of the high-risk ε4 version of the APOE gene found nine genetic signals for the disease that never…
AstraZeneca and Daiichi Sankyo reported on September 13, 2026, that patients whose advanced lung cancer is driven by a mutation in a gene called HER2 went a median of 14.3 months, the halfway point…
Genetic risk scores for common diseases predict less accurately for a person the further that person's ancestry sits from the group the score was built in, and the decline follows a straight line.…
Medical Disclaimer: This content is provided for general informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition, concern, symptom, or treatment decision.